Preclinical Mouse Models for Cancer Immunotherapy with Anti-PD-1 Highlight the Importance of Using Mouse-Specific Reagents to Reflect Clinical Settings
Asian Journal of Current Research in Clinical Cancer · 2021
DOI: 10.51847/0kvmrift7w ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Current Research in Clinical Cancer, 2021. Verfasst von T. Sato und 2 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sato, T., Tanaka, K., & Watanabe, H. (2021). Preclinical Mouse Models for Cancer Immunotherapy with Anti-PD-1 Highlight the Importance of Using Mouse-Specific Reagents to Reflect Clinical Settings. Asian Journal of Current Research in Clinical Cancer. https://doi.org/10.51847/0kvmrift7w
Vancouver
Sato T, Tanaka K, Watanabe H. Preclinical Mouse Models for Cancer Immunotherapy with Anti-PD-1 Highlight the Importance of Using Mouse-Specific Reagents to Reflect Clinical Settings. Asian Journal of Current Research in Clinical Cancer. 2021. doi:10.51847/0kvmrift7w
BibTeX
@article{Sato2021,
author = {Sato, T. and Tanaka, K. and Watanabe, H.},
title = {Preclinical Mouse Models for Cancer Immunotherapy with Anti-PD-1 Highlight the Importance of Using Mouse-Specific Reagents to Reflect Clinical Settings},
journal = {Asian Journal of Current Research in Clinical Cancer},
year = {2021},
doi = {10.51847/0kvmrift7w}
}
EUVIMED